Works matching IS 10648542 AND DT 2011 AND VI 20 AND IP 12
2
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 112
- Article
3
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 111
- Article
4
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 110
- Article
5
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 108
- Article
6
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 107
- Article
7
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 106
- Article
8
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 104
- Article
9
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 102
- Article
10
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 100
- Article
11
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 99
- Article
12
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 98
- Article
13
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 96
- Article
14
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 95
- Article
15
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 94
- Article
16
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 93
- Article
17
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 92
- Article
18
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 91
- Article
19
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 90
- Article
20
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 89
- Article
21
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 88
- Article
22
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 86
- Article
23
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 84
- Article
24
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 83
- Article
25
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 82
- Article
26
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 81
- Article
27
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 80
- Article
28
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 78
- Article
29
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 77
- Article
30
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 76
- Article
31
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 74
- Article
32
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 73
- Article
33
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 72
- Article
34
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 70
- Article
35
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 68
- Article
36
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 66
- Article
37
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 65
- Article
38
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 64
- Article
39
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 63
- Article
40
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 62
- Article
41
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 60
- Article
42
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 58
- Article
43
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 57
- Article
44
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 56
- Article
45
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 55
- Article
46
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 54
- Article
47
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 53
- Article
48
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 52
- Article
49
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 48
- Article
50
- Applied Clinical Trials, 2011, v. 20, n. 12, p. 44
- Article